We are live on ! Find out more
AEMD icon

Aethlon Medical
AEMD

20 hedge funds and large institutions have $1.38M invested in Aethlon Medical in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

640% more capital invested

Capital invested by funds: $187K → $1.38M (+$1.2M)

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

125% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 4

33% more funds holding

Funds holding: 15 → 20 (+5)

0.11% more ownership

Funds ownership: 0.04% → 0.14% (+0.11%)

Holders
20
Holders Change
+5
Holders Change %
+33.33%
% of All Funds
0.26%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
9
Increased
3
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
IC
Ikarian Capital
Texas
+$318K
2
BFM
Boothbay Fund Management
New York
+$91.9K
3
VF
Virtu Financial
New York
+$40K
4
SCA
Sassicaia Capital Advisers
New York
+$15.3K
5
UBS Group
UBS Group
Switzerland
+$13.3K

Top Sellers

1
TSS
Two Sigma Securities
New York
-$6.41K
2
BBA
Baader Bank Aktiengesellschaft
Germany
-$5.79K
3
TRCT
Tower Research Capital (TRC)
New York
-$1.73K
4
Citigroup
Citigroup
New York
-$1.16K
5
JP Morgan Chase
JP Morgan Chase
New York
-$768
Name Holding Trade Value Shares
Change 		Change in
Stake
IC
1
Ikarian Capital
Texas
$645K +$318K +9,375 New
UBS Group
2
UBS Group
Switzerland
$215K +$13.3K +391 +14%
BFM
3
Boothbay Fund Management
New York
$186K +$91.9K +2,708 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$94.9K +$5.06K +149 +12%
VF
5
Virtu Financial
New York
$81K +$40K +1,177 New
SCA
6
Sassicaia Capital Advisers
New York
$31K +$15.3K +450 New
AFGAS
7
Allegiance Financial Group Advisory Services
Virginia
$25.8K +$12.7K +375 New
Renaissance Technologies
8
Renaissance Technologies
New York
$25.2K +$12.4K +366 New
SRL
9
Scientech Research LLC
New Jersey
$19.4K +$9.57K +282 New
Two Sigma Investments
10
Two Sigma Investments
New York
$19.4K +$3.02K +89 +46%
Vanguard Group
11
Vanguard Group
Pennsylvania
$18.3K – – –
IA
12
IFP Advisors
Florida
$9.38K +$4.62K +136 New
BlackRock
13
BlackRock
New York
$6.31K – – –
TRCT
14
Tower Research Capital (TRC)
New York
$3.29K -$1.73K -51 -52%
Group One Trading
15
Group One Trading
Illinois
$1.05K – – –
SS
16
SBI Securities
Japan
$714 +$339 +10 New
Wells Fargo
17
Wells Fargo
California
$181 – – –
Osaic Holdings
18
Osaic Holdings
Arizona
$127 – – –
Bank of America
19
Bank of America
North Carolina
$98 – – –
Morgan Stanley
20
Morgan Stanley
New York
$77 – – –
BCWM
21
Bartlett & Co Wealth Management
Ohio
$22 – – –
TC
22
Truvestments Capital
Florida
$4 – – –
AF
23
Allworth Financial
California
$2 – – –
DB
24
Danske Bank
Denmark
$1 – – –
BBA
25
Baader Bank Aktiengesellschaft
Germany
– -$5.79K -217 Closed
1
2

AEMD Hedge Fund Activity: Q4 2024 in Review

20 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q4 2024, worth a combined $1.38M — up 640% from $187K a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new AEMD positions and 4 closed out — a net gain of 5 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Ikarian Capital, opening a new position worth an estimated $318K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $6.41K sold.

  • 20 institutional investors held Aethlon Medical (AEMD) as of Q4 2024, up from 15 in Q3 2024.
  • Funds reported $1.38M of Aethlon Medical stock for Q4 2024, up 640% quarter-over-quarter.
  • 9 funds opened new Aethlon Medical positions in Q4 2024 and 4 closed out, a net change of +5 holders.
  • The largest Aethlon Medical buyer in Q4 2024 was Ikarian Capital, an estimated $318K added.
  • The largest Aethlon Medical seller in Q4 2024 was Two Sigma Securities, an estimated $6.41K sold.

Based on aggregated 13F filings for Q4 2024.